COMBINED oral contraceptives
(COCs) have been shown not to
have an increased risk of venous
thromboembolism (VTE) according
to a new large Australian systematic
review and meta-analysis.
While no increased risk of VTE
with drospirenone was seen in
prospective or case control studies,
the risk of VTE was increased in
retrospective cohort and nested
case control studies.
The difference in risk of VTE based
on the choice of progestin in COCs
is, at worst, very small in absolute
terms, the authors said.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.